72 related articles for article (PubMed ID: 1725797)
1. Nitrendipine and metabolic balance.
Ferrara LA; Marotta T
J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S19-21. PubMed ID: 1725797
[TBL] [Abstract][Full Text] [Related]
2. Metabolic neutrality in nitrendipine therapy.
Mancini M; Marotta T; Ferrara LA
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S30-3. PubMed ID: 1723452
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of exogenous triglyceride removal following calcium channel blockade.
Marotta T; Ferrara LA; Pasanisi F; Rubba P; Iovine C; Mancini M
Artery; 1989; 16(6):312-26. PubMed ID: 2679494
[TBL] [Abstract][Full Text] [Related]
4. [Does long-term blood pressure reduction in patients with essential hypertension improve concomitant metabolic disorders?].
Hauner H; Meissner C
Med Klin (Munich); 1994 Aug; 89(8):403-9. PubMed ID: 7968872
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and hypertension in postmenopausal women.
Feldstein CA; Akopian M; Renauld A; Olivieri AO; Cauterucci S; Garrido D
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S145-50. PubMed ID: 11986914
[TBL] [Abstract][Full Text] [Related]
6. [Alteration of blood glucose, insulin and lipid in the offsprings of patients with essential hypertension].
Yang T; Sun M; Zhou H; Xie X
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):37-40. PubMed ID: 11938735
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension.
Fuh MM; Shieh SM; Wu DA; Chen YD; Reaven GM
Arch Intern Med; 1987 Jun; 147(6):1035-8. PubMed ID: 3296980
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of fuel metabolism in the polycystic ovary syndrome.
Wortsman J; Soler NG
Obstet Gynecol; 1982 Sep; 60(3):342-5. PubMed ID: 6214733
[TBL] [Abstract][Full Text] [Related]
10. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
11. Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension.
Malminiemi K; Lahtela JT; Huupponen R
Int J Clin Pharmacol Ther; 1995 Mar; 33(3):156-63. PubMed ID: 7599914
[TBL] [Abstract][Full Text] [Related]
12. Metabolic risk factors in white coat hypertensives.
Marchesi E; Perani G; Falaschi F; Negro C; Catalano O; Ravetta V; Finardi G
J Hum Hypertens; 1994 Jul; 8(7):475-9. PubMed ID: 7932508
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of pindolol on plasma lipids, apoproteins A, blood glucose, and serum insulin levels.
Lehtonen A
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):269-72. PubMed ID: 6430812
[TBL] [Abstract][Full Text] [Related]
14. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
Romics L; Karádi I; Rozenberczki M; Kammerer L
Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
[TBL] [Abstract][Full Text] [Related]
15. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
16. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
[TBL] [Abstract][Full Text] [Related]
17. Nitrendipine does not impair long-term glucose control in hypertensive noninsulin-dependent diabetic patients.
Giuntoli F; Galeone F; Gabbani S; Natali A; Brunelleschi G; Saba P; Stampino CG
Clin Ther; 1991; 13(2):216-23. PubMed ID: 1907527
[TBL] [Abstract][Full Text] [Related]
18. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
19. [The significance of insulin resistance and hyperlipidemia in microvascular angina (syndrome X)].
Langes K; Volk C; Schneider MA; Koschyk DH; Rinninger F; Nienaber CA
Z Kardiol; 1995 Mar; 84(3):180-9. PubMed ID: 7732710
[TBL] [Abstract][Full Text] [Related]
20. Do beta-blockers alter lipids and what are the consequences?
Holtzman E; Rosenthal T; Goldbourt U; Segal P
J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
